EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer

Nahuel Olaiz, Andrea Monti Hughes iD, Emiliano C C Pozzi, Silvia Thorp, Paula Curotto, Verónica A Trivillin, Paula S Ramos, Mónica A Palmieri, Guillermo Marshall, Amanda E Schwint, Marcela A Garabalino

Cells · 2023

DOI: 10.3390/cells12091241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Nahuel Olaiz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Pabellón I, Ciudad Universitaria, Buenos Aires C…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Mucositis, Mouth Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Atomic Energy Commission of Argentina, INC Nro.35 Resolución MINSAL 1006/2016.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boron neutron capture therapy (BNCT) combines preferential tumor uptake of 10B compounds and neutron irradiation. Electroporation induces an increase in the permeability of the cell membrane. We previously demonstrated the optimization of boron biodistribution and microdistribution employing electroporation (EP) and decahydrodecaborate (GB-10) as the boron carrier in a hamster cheek pouch oral cancer model. The aim of the present study was to evaluate if EP could improve tumor control without enhancing the radiotoxicity of BNCT in vivo mediated by GB-10 with EP 10 min after GB-10 administration. Following cancerization, tumor-bearing hamster cheek pouches were treated with GB-10/BNCT or GB-10/BNCT + EP. Irradiations were carried out at the RA-3 Reactor. The tumor response and degree of mucositis in precancerous tissue surrounding tumors were evaluated for one month post-BNCT. The overall tumor response (partial remission (PR) + complete remission (CR)) increased significantly for protocol GB-10/BNCT + EP (92%) vs. GB-10/BNCT (48%). A statistically significant increase in the CR was observed for protocol GB-10/BNCT + EP (46%) vs. GB-10/BNCT (6%). For both protocols, the radiotoxicity (mucositis) was reversible and slight/moderate. Based on these results, we concluded that electroporation improved the therapeutic efficacy of GB-10/BNCT in vivo in the hamster cheek pouch oral cancer model without increasing the radiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyMucositisMouth NeoplasmsCricetinaeAnimalsTissue DistributionBoronElectroporation

Stichwörter der Autor:innen

BNCTGB-10electroporationhamster cheek pouchin vivo irradiation studiesoral cancer

Substanzen

Boron

Autor:innen und Institutionen

  • Departamento de Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Pabellón I, Ciudad Universitaria, Buenos Aires C1428EHA, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2270, Buenos Aires C1425FQD, Argentina.
  • Departamento Radiobiología, Comisión Nacional de Energía Atómica (CNEA), Centro Atómico Constituyentes (CAC), Av. General Paz 1499, San Martín, Buenos Aires B1650KNA, Argentina.
  • Departamento de Reactores de Investigación y Producción, Comisión Nacional de Energía Atómica (CNEA), Centro Atómico Ezeiza (CAE), Camino Real Presbítero González y Aragón 15, Buenos Aires B1802AYA, Argentina.
  • Sub-Gerencia Instrumentación y Control, Comisión Nacional de Energía Atómica (CNEA), Centro Atómico Ezeiza (CAE), Camino Real Presbítero González y Aragón 15, Buenos Aires B1802AYA, Argentina.
  • Departamento de Biodiversidad y Biología Experimental, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Pabellón II, Ciudad Universitaria, Buenos Aires C1428EHA, Argentina.

ORCID-Profile: Andrea Monti Hughes

Förderung

  • National Atomic Energy Commission of Argentina
  • INC Nro.35 Resolución MINSAL 1006/2016

Zitieren

APA

Olaiz, N., Monti Hughes, A., Pozzi, E. C. C., Thorp, S., Curotto, P., Trivillin, V. A., Ramos, P. S., Palmieri, M. A., Marshall, G., Schwint, A. E., & Garabalino, M. A. (2023). Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer. Cells. https://doi.org/10.3390/cells12091241

Vancouver

Olaiz N, Monti Hughes A, Pozzi ECC, Thorp S, Curotto P, Trivillin VA, et al. Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer. Cells. 2023. doi:10.3390/cells12091241

BibTeX
@article{Olaiz2023,
  author = {Olaiz, Nahuel and Monti Hughes, Andrea and Pozzi, Emiliano C C and Thorp, Silvia and Curotto, Paula and Trivillin, Verónica A and Ramos, Paula S and Palmieri, Mónica A and Marshall, Guillermo and Schwint, Amanda E and Garabalino, Marcela A},
  title = {Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12091241}
}
Kostenlos starten →